Xenon Pharmaceuticals dismisses KPMG, appoints PwC as independent auditor

Xenon Pharmaceuticals Inc.

Audit Committee dismissed KPMG as independent registered public accounting firm on March 3, 2025.
No disagreements or reportable events with KPMG during 2024, 2023, or interim period through March 3, 2025.
Audit Committee approved engagement of PricewaterhouseCoopers LLP for fiscal year ending Dec 31, 2025.
No prior consultations with PwC regarding accounting principles or audit scope during the two most recent fiscal years.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.